{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:06:35Z","timestamp":1781157995957,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council, Taiwan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.jviromet.2012.11.035","type":"journal-article","created":{"date-parts":[[2013,1,11]],"date-time":"2013-01-11T17:04:00Z","timestamp":1357923840000},"page":"58-64","source":"Crossref","is-referenced-by-count":15,"title":["Easy expression of the C-terminal heavy chain domain of botulinum neurotoxin serotype A as a vaccine candidate using a bi-cistronic baculovirus system"],"prefix":"10.1016","volume":"189","author":[{"given":"Oliver B.","family":"Villaflores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chein-Ming","family":"Hsei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Yi","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiunn-Jye","family":"Wey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yi","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Hwa","family":"Shyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Lun","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Ming","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Der-Jiang","family":"Chiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzong-Yuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2012.11.035_bib0005","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jmb.2006.07.040","article-title":"A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1\u2013A4","volume":"362","author":"Arndt","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0010","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon","volume":"285","author":"Arnon","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jviromet.2012.11.035_bib0015","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1002\/mds.20020","article-title":"Basic immunological aspects of botulinum toxin therapy","volume":"19","author":"Atassi","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.pep.2004.05.009","article-title":"The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability","volume":"37","author":"Baldwin","year":"2004","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0025","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1128\/IAI.01025-07","article-title":"Subunit vaccine against the seven serotypes of botulism","volume":"76","author":"Baldwin","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pep.2009.12.013","article-title":"Recombinant derivatives of botulinum neurotoxin A engineered for trafficking studies and neuronal delivery","volume":"71","author":"Band","year":"2010","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2005.04.017","article-title":"Expanding use of botulinum toxin","volume":"235","author":"Bhidayasiri","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0040","doi-asserted-by":"crossref","first-page":"9153","DOI":"10.1016\/S0021-9258(19)38824-6","article-title":"The complete sequence of botulinum neurotoxin type A and comparison with other clostridial neurotoxins","volume":"265","author":"Binz","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0928-4257(94)90086-8","article-title":"Inhibition of neurotransmitter release by clostridial neurotoxins correlates with specific proteolysis of synaptosomal proteins","volume":"88","author":"Blasi","year":"1994","journal-title":"J. Physiol. Paris"},{"key":"10.1016\/j.jviromet.2012.11.035_bib0050","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/365160a0","article-title":"Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25","volume":"365","author":"Blasi","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2012.11.035_bib0055","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1128\/IAI.66.10.4817-4822.1998","article-title":"Purification potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate","volume":"66","author":"Byrne","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0060","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1128\/IAI.66.6.2420-2425.1998","article-title":"Biophysical characterization of the stability of the 150-kilodalton botulinum toxin the nontoxic component, and the 900-kilodalton botulinum toxin complex species","volume":"66","author":"Chen","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pep.2009.11.007","article-title":"Improved soluble expression and characterization of the Hc domain of Clostridium botulinum neurotoxin serotype A in Escherichia coli by using a PCR-synthesized gene and a Trx co-expression strain","volume":"71","author":"Chen","year":"2010","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0070","doi-asserted-by":"crossref","first-page":"1101071","DOI":"10.1271\/bbb.110107","article-title":"Expression of recombinant human interferon-\u03b3 with anti-viral activity in the bi-cistronic baculovirus-insect\/larval system","volume":"75","author":"Chen","year":"2011","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0075","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbrc.2005.07.116","article-title":"Development of a bi-cistronic baculovirus expression vector by the Rhopalosiphum padi virus 5\u2032 internal ribosome entry site","volume":"335","author":"Chen","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0080","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/IAI.63.7.2738-2742.1995","article-title":"Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli","volume":"63","author":"Clayton","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0085","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jviromet.2012.11.035_bib0090","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/mds.20003","article-title":"Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin","volume":"19","author":"Erbguth","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0095","first-page":"1","article-title":"Ueber einen neuen anaeroben Bacillus und seine beziehungen zun botulismus","volume":"26","author":"Ermengem","year":"1897","journal-title":"Z. Hyg. Infektionskr."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0100","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4049\/jimmunol.20.4.305","article-title":"Antigenic value of botulinum toxoids kept one year at ice box temperature","volume":"20","author":"Graham","year":"1931","journal-title":"J. Immunol."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0215","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1586\/14760584.7.3.363","article-title":"Baculovirus as an expression and\/or delivery vehicle for vaccine antigens","volume":"7","author":"Hu","year":"2008","journal-title":"Expert Review of Vaccine."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0105","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s00705-008-0260-1","article-title":"An extensive analysis on the global codon usage pattern of baculoviruses","volume":"153","author":"Jiang","year":"2008","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0110","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1128\/CVI.00117-08","article-title":"Characterization of new formalin-detoxified botulinum neurotoxin toxoids","volume":"15","author":"Keller","year":"2008","journal-title":"Clin. Vac. Immunol."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0115","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jviromet.2011.05.015","article-title":"Cell-based analysis of Chikungunya virus membrane fusion using baculovirus-expression vectors","volume":"175","author":"Kuo","year":"2011","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2012.11.035_bib0120","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2012.11.035_bib0125","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/0041-0101(95)00072-T","article-title":"Expression of a large, nontoxic fragment of botulinum neurotoxin serotype A and its use as an immunogen","volume":"33","author":"LaPenotiere","year":"1995","journal-title":"Toxicon"},{"key":"10.1016\/j.jviromet.2012.11.035_bib0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajog.2006.03.108","article-title":"Botulinum toxin: from life-threatening disease to novel medical therapy","volume":"196","author":"Mahajan","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0135","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.biologicals.2009.09.008","article-title":"Cloning high level expression and immunogenicity of 1163-1256 residues of C-terminal heavy chain of C. botulinum neurotoxin type E","volume":"38","author":"Mansour","year":"2010","journal-title":"Biologicals"},{"key":"10.1016\/j.jviromet.2012.11.035_bib0140","first-page":"161","article-title":"Molecular genetics of clostridial neurotoxins","volume":"195","author":"Minton","year":"1995","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0145","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/978-3-642-61105-6_32","article-title":"The mechanism of action of tetanus and botulinum neurotoxin","volume":"18","author":"Montecucco","year":"1996","journal-title":"Arch. Toxicol. Suppl."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/taap.1994.1181","article-title":"Measurement of botulinum toxin activity: evaluation of the lethality assay","volume":"128","author":"Pearce","year":"1994","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0155","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1006\/prep.2000.1256","article-title":"Production and purification of the heavy chain fragment C of botulinum neurotoxin serotype A, expressed in the methylotrophic yeast Pichia pastoris","volume":"19","author":"Potter","year":"2000","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0160","first-page":"285","article-title":"Cellular and molecular mode of action of botulinum and tetanus neurotoxins","volume":"vol. 2","author":"Poulain","year":"1997"},{"key":"10.1016\/j.jviromet.2012.11.035_bib0165","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0170","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/scel.1994.1028","article-title":"Clostridial neurotoxins as tools to investigate the molecular events of neurotransmitter release","volume":"5","author":"Schiavo","year":"1994","journal-title":"Semin. Cell Biol."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0175","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jbiotec.2006.07.022","article-title":"Cell bank characterization and fermentation optimization for production of recombinant heavy chain C-terminal fragment of botulinum neurotoxin serotype E (rBoNTE(Hc):Antigen E) by Pichia pastoris","volume":"127","author":"Sinha","year":"2007","journal-title":"J. Biotechnol."},{"issue":"Suppl. 4","key":"10.1016\/j.jviromet.2012.11.035_bib0180","doi-asserted-by":"crossref","first-page":"D33","DOI":"10.1016\/j.vaccine.2009.08.059","article-title":"Botulism and vaccines for its prevention","volume":"27","author":"Smith","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2012.11.035_bib0185","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1745-7254.2006.00372.x","article-title":"Disulfide bond reduction corresponds to dimerization and hydrophobicity changes of Clostridium botulinum type A neurotoxin","volume":"27","author":"Wey","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0190","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1128\/IAI.00166-11","article-title":"Rapid immune responses to a botulinum neurotoxin Hc subunit vaccine through in vivo targeting to antigen-presenting cells","volume":"79","author":"White","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0168-1656(00)00247-9","article-title":"Expression of highly controllable genes in insect cells using a modified tetracycline-regulated gene expression system","volume":"80","author":"Wu","year":"2000","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0220","first-page":"1","article-title":"A bi-cistronic baculovirus expression vector for improved recombinant protein production","volume":"3","author":"Wu","year":"2012","journal-title":"Bioengineered Bugs."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0200","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jbiotec.2006.07.012","article-title":"Select what you need: a comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes","volume":"127","author":"Yin","year":"2007","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0205","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1128\/CVI.00239-08","article-title":"Evaluation of a recombinant Hc of Clostridium botulinum neurotoxin serotype F as an effective subunit vaccine","volume":"15","author":"Yu","year":"2008","journal-title":"Clin. Vac. Immunol."},{"key":"10.1016\/j.jviromet.2012.11.035_bib0210","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pep.2003.10.015","article-title":"Cloning high-level expression, single-step purification, and binding activity of His6-tagged recombinant type B botulinum neurotoxin heavy chain transmembrane and binding domain","volume":"34","author":"Zhou","year":"2004","journal-title":"Protein Expr. Purif."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093412004272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093412004272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T16:10:26Z","timestamp":1687968626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093412004272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0166093412004272"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2012.11.035","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}